abstract |
A combination composition comprising a selective estrogen receptor modulator and a sex steroid precursor selected from the group consisting of dehydroepiandrosterone (DHEA), dehydroepiandrosterone sulfate, androst-5-ene-3 â,17â-diol and 4-androstene-3,17-dione. Also disclosed is the use of such to treat cancers, and kits comprising such. |